Pages that link to "Q74561892"
Jump to navigation
Jump to search
The following pages link to Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy (Q74561892):
Displaying 50 items.
- A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers (Q24535055) (← links)
- Pirfenidone prevents the development of a vulnerable substrate for atrial fibrillation in a canine model of heart failure (Q24684669) (← links)
- Targeting matrix metalloproteinases in heart disease: lessons from endogenous inhibitors (Q26830555) (← links)
- Statins in heart failure: do we need another trial? (Q26998966) (← links)
- 17beta-Estradiol inhibits matrix metalloproteinase-2 transcription via MAP kinase in fibroblasts (Q28568936) (← links)
- Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat (Q30414170) (← links)
- Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy (Q30479528) (← links)
- Autologous bone marrow cell transplantation improves left ventricular function in rabbit hearts with cardiomyopathy via myocardial regeneration-unrelated mechanisms (Q33244214) (← links)
- Tauroursodeoxycholic acid (TUDCA) attenuates pressure overload-induced cardiac remodeling by reducing endoplasmic reticulum stress (Q33585295) (← links)
- Intramyocardial fibroblast myocyte communication (Q33586605) (← links)
- Membrane-associated matrix proteolysis and heart failure. (Q33632033) (← links)
- Plasma tissue inhibitor of metalloproteinase-1 and matrix metalloproteinase-9: novel indicators of left ventricular remodelling and prognosis after acute myocardial infarction (Q34138706) (← links)
- Genomics and the pathophysiology of heart failure (Q34221034) (← links)
- Cardiac-restricted overexpression or deletion of tissue inhibitor of matrix metalloproteinase-4: differential effects on left ventricular structure and function following pressure overload-induced hypertrophy. (Q34296764) (← links)
- Matrix metalloproteinases in the progression of heart failure: potential therapeutic implications (Q34340393) (← links)
- Matrix metalloproteinase inhibition and the prevention of heart failure (Q34399554) (← links)
- Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging (Q34518419) (← links)
- Electrical and structural remodeling of the failing ventricle (Q34578568) (← links)
- Determinants of extracellular matrix remodelling are differentially expressed in paediatric and adult dilated cardiomyopathy (Q34584572) (← links)
- Exercise training reduces fibrosis and matrix metalloproteinase dysregulation in the aging rat heart (Q34592384) (← links)
- Aldosterone receptor blockade in the management of heart failure (Q34623717) (← links)
- Matrix metalloproteinase disruption of the extracellular matrix and cardiac dysfunction (Q34635631) (← links)
- Novel association between plasma matrix metalloproteinase-9 and risk of incident atrial fibrillation in a case-cohort study: the Atherosclerosis Risk in Communities study (Q34648629) (← links)
- Myocardial matrix metalloproteinase-2: inside out and upside down. (Q35032465) (← links)
- Accuracy and reproducibility of absolute quantification of myocardial focal tracer uptake from molecularly targeted SPECT/CT: a canine validation (Q35109809) (← links)
- Pathogenetic basis of myocardial dysfunction and amenability to reversal (Q35146909) (← links)
- Fibrinolytic function and atrial fibrillation (Q35158979) (← links)
- Blood pressure control predicts plasma matrix metalloproteinase-9 in diabetes mellitus type II. (Q35232260) (← links)
- Influence of spironolactone on matrix metalloproteinase-2 in acute decompensated heart failure (Q35557972) (← links)
- Clinical implications of matrix metalloproteinases (Q35567569) (← links)
- Angiotensin II receptor blockade prevents microangiopathy and preserves diastolic function in the diabetic rat heart (Q35581579) (← links)
- Changes in the myocardial interstitium and contribution to the progression of heart failure (Q35582221) (← links)
- Myocardial remodeling in viral heart disease: possible interactions between inflammatory mediators and MMP-TIMP system (Q35636517) (← links)
- Regulation of matrix metalloproteinases by cytokines and reactive oxygen/nitrogen species in the myocardium. (Q35636526) (← links)
- Matrix metalloproteinases: pathways of induction by bioactive molecules (Q35636530) (← links)
- Recovery from decompensated heart failure is associated with a distinct, phase-dependent gene expression profile (Q36098855) (← links)
- Heart failure following anterior myocardial infarction: an indication for ventricular restoration, a surgical method to reverse post-infarction remodeling (Q36123735) (← links)
- Effect of MR blockade on collagen formation and cardiovascular disease with a specific emphasis on heart failure (Q36158058) (← links)
- Disruptions and detours in the myocardial matrix highway and heart failure (Q36203117) (← links)
- Evaluation of serum prolidase activity in patients with slow coronary flow (Q36245043) (← links)
- Systems biology and biomechanical model of heart failure (Q36302132) (← links)
- Plasma matrix metalloproteinase-9 and left ventricular remodelling after acute myocardial infarction in man: a prospective cohort study (Q36387323) (← links)
- Screening for ventricular remodeling (Q36473364) (← links)
- Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance (Q36557850) (← links)
- Novel and potential future biomarkers for assessment of the severity and prognosis of chronic heart failure : a clinical review (Q36666482) (← links)
- Ablation of Matrix Metalloproteinase-9 Prevents Cardiomyocytes Contractile Dysfunction in Diabetics (Q36685873) (← links)
- Investigation of MMP-2 and MMP-9 activities in canine sera with dilated cardiomyopathy (Q36787202) (← links)
- Imaging of matrix metalloproteinase activation and left ventricular remodeling (Q36790142) (← links)
- Circulating matrix metalloproteinases and tissue inhibitors of metalloproteinases in cardiac amyloidosis (Q36824706) (← links)
- Reverse remodeling during long-term mechanical unloading of the left ventricle (Q36891200) (← links)